News Gilead cancer drug can stay on EU market Safety experts recommend antibiotics after Zydelig treatment.
US Gilead hopes cut-price pan-genomic hep C combo will revive s... Epclusa is first treatment for all six major virus genotypes.
Articles Pharma news round-up: Pfizer-Allergan merger scrapped, Gilea... A round-up of this week's top pharma and healthcare news – plus reaction from social media. Marco Ricci reports.
Articles Raising the bar: can Gilead’s next challenge be even bigger ... How do you follow a genuine drug breakthrough, a cure for hepatitis C?
News UK digital health funding should be ringfenced, says report IT industry group techUK has called on the government to guarantee funding for digital transformation and cyber resilience in health and social care
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
